According to GlobalData’s medical device pipeline database, 19 Handheld Ultrasound (HHU) Systems devices are in various stages of development globally. GlobalData’s report Hand Held Ultrasound (HHU) Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 12 are in active development, while the remaining seven are in an inactive stage of development. There are six products in the early stages of development, and the remaining six are in the late stages of development.
Handheld units (HHU) are those ultrasound systems which can be carried from one place to another for point of care diagnosis. They come in three primary configurations, including hand-held, laptop, and tablet. One unit is defined as one HHU system.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
See Also:
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Handheld Ultrasound (HHU) Systems pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Handheld Ultrasound (HHU) Systems devices. Overall, most of these Handheld Ultrasound (HHU) Systems pipeline devices are being developed by private entities.
Key players involved in the active development of Handheld Ultrasound (HHU) Systems include PulseNmore, Vanderbilt University, Rimed, Staffordshire University, University Health Network, University of Michigan Pediatric Device Consortium, Analogic, Arbor Ultrasound Technologies, BK Ultrasound and Butterfly Network.
For a complete picture of the developmental pipeline for Handheld Ultrasound (HHU) Systems devices, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
